---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-001304"
form_type: "8-K"
ticker: "PTGX"
cik: "0001377121"
company_name: "Protagonist Therapeutics, Inc"
filed_at: "2025-01-06T23:59:59+00:00"
generated_at: "2026-05-28T10:01:59.425831+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Protagonist Therapeutics appoints Suneel Gupta as EVP, Clinical Development

## Summary
- Effective Jan 1, 2025, Suneel Gupta transitioned from Chief Development Officer to EVP, Clinical Development.
- Gupta, previously CDO, now serves as Executive Vice President, Clinical Development.
- No other officer changes were reported in the filing.

## SEC filing metadata
- accession: 0001104659-25-001304
- form_type: 8-K
- ticker: PTGX
- cik: 0001377121
- company_name: Protagonist Therapeutics, Inc
- filed_at: 2025-01-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1377121/000110465925001304/0001104659-25-001304-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1377121/000110465925001304/tm251959d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-001304
- JSON: https://secwatch.observer/filing/0001104659-25-001304.json
- Plain text: https://secwatch.observer/filing/0001104659-25-001304.txt

## Key facts
- Executive change
  Suneel Gupta changed role as Executive Vice President, Clinical Development at Protagonist Therapeutics, Inc.
  - Action: transitioned
  - Role: Executive Vice President, Clinical Development
  source text: Effective January 1, 2025, Suneel Gupta, Ph.D., Protagonist Therapeutics, Inc.’s Chief Development Officer, transitioned to Executive Vice President, Clinical Development.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1377121/000110465925001304/0001104659-25-001304-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.